Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma despite Normal Coagulation Parameters

Ilhami BERBER¹, Mehmet Ali ERKURT¹, Ilknur NIZAM^1, , Irfan KUKU¹, Emin KAYA¹, Serkan UNLU² and Mikail YILMAZ³

¹Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey

²Department of Radiology, Faculty of Medicine, Inonu University, Malatya, Turkey

³Department of Dermatology, Faculty of Medicine, Inonu University, Malatya, Turkey

Cite this paper

Ilhami BERBER, Mehmet Ali ERKURT, Ilknur NIZAM, Irfan KUKU, Emin KAYA, Serkan UNLU and Mikail YILMAZ. Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma despite Normal Coagulation Parameters. American Journal of Medical Case Reports. 2015; 3(3):82-84. doi: 10.12691/AJMCR-3-3-8

Abstract

Diclofenac is a member of nonsteroidal anti-inflammatory drugs. In Turkey, ıt is often used as a analgesic. Diclofenac may very occasionally lead to spontaneous extensive ecchymosis and hematoma despite a normal coagulation parameters. In this paper, we report one patient who presented with spontaneous extensive ecchymosis and was diagnosed with a hematoma in the anterior chest wall associated with diclofenac use despite normal coagulation parameters. In countries like Turkey where NSAID are used extensively, drug history should be questioned in patients presenting with spontaneous bleeding and have normal coagulation parameters by physicians.

Keywords

complication, diclofenac, spontaneous extensive ecchymosis, hematoma

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Raineri-Gerber I, Von Felten A. Inhibition of thrombocyte function by nonsteroidal anti-rheumatic agents: a comparative study between diclofenac, acemetacin, mefenamic acid and ibuprofen. Schweiz Med Wochenschr1991;121: 783-787.
[2]	Jerome Z. Litt. Litt’s D.E.R.M, Drug Eruptions & Reactions Manual. 17th Ed. Informa UK Limited; 26 February 2011.
[3]	Odom RB, James WD, Berger TG (eds). Cutaneous symptoms, signs, and diagnosis. Andrews’ Diseases of the Skin. 9th ed. Philadelphia, WB Saunders, 2000: 13-21.
[4]	Stewart PS, Kinney MR. The abdomen, thigh, and arm as sites for subcutaneous sodium heparin injections. Nursing Research 1991; 40: 204-207
[5]	Stobbe H, Hüge W. Hematotoxic lesions caused by non-steroidal antirheumatic agents. ZGesamte Inn Med 1980; 35: 165-169.
[6]	Kramer MR, Levene C, Hershko C. Severe reversible autoimmune haemolyticanaemia and thrombocytopenia associated with diclofenac therapy. Scand J Haematol1986; 36: 118-120
[7]	Epstein M, Vickars L, Stein H. Diclofenac induced immune thrombocytopenia. J Rheumatol1990: 17: 1403-1404.
[8]	Jick H, Derby LE, García Rodríguez LA, Jick SS, Dean AD. Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study. Pharmacotherapy 1993; 13: 212-217.
[9]	Kim HL, Kovacs MJ. Diclofenac-associated thrombocytopenia and neutropenia. Ann Pharmacother1995: 29; 713-715.
[10]	Varoga D, Drescher W, Lippross S, Pufe T, Schütz R. Nonsteroidal anti-inflammatory drug (NSAID)-related spontaneous compartment syndrome resulting from severe platelet dysfunction. J Trauma 2009; 66: 1251-1252.
[11]	Hengge UR, Jochum C, Tschakarjan E, Maschke J, Erbel R, Schmid KW, Otterbach F. Purpurafulminans. A fatalconsequence of a widelyusedmedication? Hautarzt 2002; 53(7): 483-487.
[12]	Coutre S. Congenitalandacquireddisorders of plateletfunction. www.uptodate.com (updatedAug 06, 2014).